FDA found HACCP violations at Procesadora Marina, a Venezuelan crabmeat processor; RTE crab may be unsafe.
What happened
FDA conducted a remote regulatory assessment of the seafood processing facility on May 13, 2024 through May 17, 2024 and found serious violations of the seafood HACCP rule. FDA said the company’s plan did not adequately control Clostridium botulinum growth and toxin formation in reduced-oxygen-packaged crabmeat or adequately control cooling. FDA also said it had not received a response to the issues discussed at the close of the assessment.
What FDA found
The HACCP plan’s critical limits for final product storage and labeling were not adequate to control Clostridium botulinum growth and toxin formation in reduced-oxygen-packaged crabmeat.
21 CFR 123.6(c)(3)The plan did not require frozen reduced-oxygen-packaged crabmeat labels to tell users to keep the product frozen and thaw it properly, and did not require a time-temperature indicator on each refrigerated package.
21 CFR 123.6(c)(3)The cooling critical limits were inadequate because they did not include cooling cooked crabs under fans before placing them in the cooler.
21 CFR 123.6(c)(3)The final product storage monitoring procedure was inadequate because it used hourly cooler temperature checks instead of continuous ambient time and temperature monitoring with at least daily visual checks of recorded data.
21 CFR 123.6(c)(4)
What FDA wants
FDA asks the company to respond in writing within 15 working days describing corrections, including a revised HACCP plan and monitoring records in English; if corrections cannot be completed in that time, the company should explain why and state when it will finish.
Who should pay attention
- U.S. importers and brands selling ready-to-eat crabmeat
- distributors and retailers of refrigerated or frozen seafood
- foreign seafood processors using reduced-oxygen packaging
This is a summary. Read the original letter on fda.gov.